Article Information
vol. 8 no. 1
Published By
Online ISSN
History
- Received May 14, 2021
- Accepted October 24, 2021
- Published online February 21, 2022.
Article Versions
- previous version (December 16, 2021 - 01:38).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Licence 4.0.
Author Information
- Alan Martin1,
- Dhvani Shah2,
- Kerigo Ndirangu2,
- Glenn A. Anley1,
- Gabriel Okorogheye1,
- Melanie Schroeder3,
- Nancy Risebrough4 and
- Afisi S. Ismaila5,6⇑
- 1Value Evidence and Outcomes, GlaxoSmithKline, Uxbridge, UK
- 2ICON Plc, Health Economics, New York, NY, USA
- 3Value Evidence and Outcomes, GlaxoSmithKline, Brentford, UK
- 4ICON Plc, Health Economics, Toronto, ON, Canada
- 5Value Evidence and Outcomes, GlaxoSmithKline, Collegeville, PA, USA
- 6Dept of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada
- Corresponding author: Afisi S. Ismaila (afisi.s.ismaila{at}gsk.com)
Funding
GlaxoSmithKline